Wonkam, Ambroise https://orcid.org/0000-0003-1420-9051
Esoh, Kevin https://orcid.org/0000-0002-4024-5681
Levine, Rachel M. https://orcid.org/0000-0002-3684-2950
Ngo Bitoungui, Valentina Josiane https://orcid.org/0000-0002-2845-8879
Mnika, Khuthala
Nimmagadda, Nikitha https://orcid.org/0000-0003-1648-6335
Dempsey, Erin A. D.
Nkya, Siana
Sangeda, Raphael Z. https://orcid.org/0000-0002-6574-5308
Nembaware, Victoria
Morrice, Jack
Osman, Fujr https://orcid.org/0000-0003-4993-996X
Beer, Michael A. https://orcid.org/0000-0001-9955-3809
Makani, Julie
Mulder, Nicola https://orcid.org/0000-0003-4905-0941
Lettre, Guillaume https://orcid.org/0000-0002-7740-3399
Steinberg, Martin H.
Latanich, Rachel
Casella, James F. https://orcid.org/0000-0002-2846-9420
Drehmer, Daiana https://orcid.org/0000-0002-7329-2425
Arking, Dan E. https://orcid.org/0000-0001-8980-8695
Chimusa, Emile R. https://orcid.org/0000-0001-8846-2047
Yen, Jonathan S. https://orcid.org/0000-0002-9432-9450
Newby, Gregory A.
Antonarakis, Stylianos E. https://orcid.org/0000-0001-8907-5823
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (1U01HG007459)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (U24‐HL‐135600)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01MH127692)
Article History
Received: 5 December 2023
Accepted: 20 February 2025
First Online: 1 March 2025
Competing interests
: J.S.Y. is an equity owner of Beam Therapeutics, and consultant for Orna, Merck, and Portal Bio. The remaining authors declare no competing interests.